117 related articles for article (PubMed ID: 1475408)
1. Human epidermal growth factor-on molecular forms present in urine and blood.
Nexø E; Jørgensen E; Hansen MR
Regul Pept; 1992 Nov; 42(1-2):75-84. PubMed ID: 1475408
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human epidermal growth factor in human serum and urine under native conditions.
Aybay C; Karakus R; Yucel A
Cytokine; 2006 Jul; 35(1-2):36-43. PubMed ID: 16908178
[TBL] [Abstract][Full Text] [Related]
3. An immunoassay designed to quantitate different molecular forms of rat urinary epidermal growth factor with equimolar potency: application on fresh rat urine.
Jørgensen PE; Vinter-Jensen L; Nexø E
Scand J Clin Lab Invest; 1996 Feb; 56(1):25-36. PubMed ID: 8850169
[TBL] [Abstract][Full Text] [Related]
4. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus.
Parries G; Chen K; Misono KS; Cohen S
J Biol Chem; 1995 Nov; 270(46):27954-60. PubMed ID: 7499272
[TBL] [Abstract][Full Text] [Related]
5. The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.
Chen R; Jin G; McIntyre TM
J Biol Chem; 2017 Jun; 292(24):10112-10122. PubMed ID: 28455445
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a low and a high molecular weight form of epidermal growth factor from rat urine.
Nexø E; Jørgensen PE; Thim L; Roepstorff P
Biochim Biophys Acta; 1990 Mar; 1037(3):388-93. PubMed ID: 2310752
[TBL] [Abstract][Full Text] [Related]
7. Renal uptake and excretion of epidermal growth factor from plasma in the rat.
Jørgensen PE; Rasmussen TN; Skov Olsen P; Raaberg L; Seier Poulsen S; Nexø E
Regul Pept; 1990 May; 28(3):273-81. PubMed ID: 2377743
[TBL] [Abstract][Full Text] [Related]
8. The urinary excretion of epidermal growth factor in the rat is reduced by aprotinin, a proteinase inhibitor.
Jørgensen PE; Raaberg L; Poulsen SS; Nexø E
Regul Pept; 1990 Nov; 31(2):115-24. PubMed ID: 1702550
[TBL] [Abstract][Full Text] [Related]
9. Human serum and plasma have different sources of epidermal growth factor.
Lev-Ran A; Hwang DL; Snyder DS
Am J Physiol; 1990 Sep; 259(3 Pt 2):R545-8. PubMed ID: 2396713
[TBL] [Abstract][Full Text] [Related]
10. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
11. Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets.
Pesonen K; Viinikka L; Myllylä G; Kiuru J; Perheentupa J
J Clin Endocrinol Metab; 1989 Feb; 68(2):486-91. PubMed ID: 2645310
[TBL] [Abstract][Full Text] [Related]
12. [Human epidermal growth factor(urogastrone) in human fluids detected by radioreceptor assay].
Nakamura K; Imai Y; Matuzaki F
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1587-96. PubMed ID: 6607183
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of growth factors in patients with ovarian cancer.
Feldkämper M; Enderle-Schmitt U; Hackenberg R; Schulz KD
Eur J Cancer; 1994; 30A(12):1851-8. PubMed ID: 7880617
[TBL] [Abstract][Full Text] [Related]
14. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
Oka Y; Orth DN
J Clin Invest; 1983 Jul; 72(1):249-59. PubMed ID: 6603475
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a novel growth factor from human breast cancer cells.
Lupu R; Wellstein A; Sheridan J; Ennis BW; Zugmaier G; Katz D; Lippman ME; Dickson RB
Biochemistry; 1992 Aug; 31(32):7330-40. PubMed ID: 1324710
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for high molecular weight form of human epidermal growth factor.
Koga J; Nishimuro S; Shirono H; Ito C; Yamamoto Y; Matsuo A; Kurobe M; Hayashi K
Biochem Int; 1989 Aug; 19(2):445-52. PubMed ID: 2818606
[TBL] [Abstract][Full Text] [Related]
17. The source of urinary epidermal growth factor in humans.
Callegari C; Laborde NP; Buenaflor G; Nascimento CG; Brasel JA; Fisher DA
Eur J Appl Physiol Occup Physiol; 1988; 58(1-2):26-31. PubMed ID: 3264526
[TBL] [Abstract][Full Text] [Related]
18. Decreased urinary epidermal growth factor in children with acute renal failure: epidermal growth factor/creatinine ratio not a reliable parameter for urinary epidermal growth factor excretion.
Tsau YK; Sheu JN; Chen CH; Teng RJ; Chen HC
Pediatr Res; 1996 Jan; 39(1):20-24. PubMed ID: 8825381
[TBL] [Abstract][Full Text] [Related]
19. Factors in biological fluids affect gel filtration behavior of epidermal growth factor.
Jenzano JW; Featherstone GL; Lundblad RL
Pept Res; 1992; 5(5):255-7. PubMed ID: 1450518
[TBL] [Abstract][Full Text] [Related]
20. EGF receptor-binding activity in the urine of normal horses and horses affected by chronic laminitis.
Grosenbaugh DA; Amoss MS; Hood DM; Williams JD
Domest Anim Endocrinol; 1990 Jul; 7(3):277-89. PubMed ID: 2390863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
